|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus
surgery alone for resectable gastroesophageal cancer. N Engl J.
355:11–20. 2006. View Article : Google Scholar
|
|
3
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeng CJ, McCarroll SA, Martin TF, Floor E,
Adams J, Krantz D, Butz S, Edwards R and Schweitzer ES: Thy-1 is a
component common to multiple populations of synaptic vesicles. J
Cell Biol. 140:685–698. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawamura K, Hiroshima K, Suzuki T, Chai K,
Yamaguchi N, Shingyoji M, Yusa T, Tada Y, Takiguchi Y, Tatsumi K,
et al: CD90 is a diagnostic marker to differentiate between
malignant pleural mesothelioma and lung carcinoma with
immunohistochemistry. Am J Clin Pathol. 140:544–549. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shaikh MV, Kala M and Nivsarkar M: CD90 a
potential cancer stem cell marker and a therapeutic target. Cancer
Biomark. 16:301–307. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar A, Bhanja A, Bhattacharyya J and
Jaganathan BG: Multiple roles of CD90 in cancer. Tumour Biol.
37:11611–11622. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu J, Thakolwiboon S, Liu X, Zhang M and
Lubman DM: Overexpression of CD90 (Thy-1) in pancreatic
adenocarcinoma present in the tumor microenvironment. PLoS One.
9:e1155072014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lung HL, Cheung AK, Cheng Y, Kwong FM, Lo
PH, Law EW, Chua D, Zabarovsky ER, Wang N, Tsao SW, et al:
Functional characterization of THY1 as a tumor suppressor gene with
antiinvasive activity in nasopharyngeal carcinoma. Int J Cancer.
127:304–312. 2010.PubMed/NCBI
|
|
11
|
Tang KH, Dai YD, Tong M, Chan YP, Kwan PS,
Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, et al: A CD90(+)
tumor-initiating cell population with an aggressive signature and
metastatic capacity in esophageal cancer. Cancer Res. 73:2322–2332.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pirozzi G, Tirino V, Camerlingo R, La
Rocca A, Martucci N, Scognamiglio G, Franco R, Cantile M, Normanno
N and Rocco G: Prognostic value of cancer stem cells,
epithelial-mesenchymal transition and circulating tumor cells in
lung cancer. Oncol Rep. 29:1763–1768. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu JW, Chang JG, Yeh KT, Chen RM, Tsai JJ
and Hu RM: Overexpression of Thy1/CD90 in human hepatocellular
carcinoma is associated with HBV infection and poor prognosis. Acta
Histochem. 113:833–838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu GC, Gao L, He J, Long Y, Liao S, Wang
H, Li X, Yi W, Pei Z, Wu M, et al: CD90 is upregulated in gastric
cancer tissues and inhibits gastric cancer cell apoptosis by
modulating the expression level of SPARC protein. Oncol Rep.
34:2497–2506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Martinez-Outschoorn UE, Peiris-Pagés M,
Pestell RG, Sotgia F and Lisanti MP: Cancer metabolism: A
therapeutic perspective. Nat Rev Clin Oncol. 14:1132017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Le A, Cooper CR, Gouw AM, Dinavahi R,
Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL and Dang
CV: Inhibition of lactate dehydrogenase A induces oxidative stress
and inhibits tumor progression. Proc Natl Acad Sci USA.
107:2037–2042. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Doherty JR and Cleveland JL: Targeting
lactate metabolism for cancer therapeutics. J Clin Invest.
123:3685–3692. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yuan LW, Yamashita H and Seto Y: Glucose
metabolism in gastric cancer: The cutting-edge. World J
Gastroenterol. 22:2046–2059. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song H, Wang L, Liu HL, Wu XB, Wang HS,
Liu ZH, Li Y, Diao DC, Chen HL and Peng JS: Tissue metabolomic
fingerprinting reveals metabolic disorders associated with human
gastric cancer morbidity. Oncol Rep. 26:431–438. 2011.PubMed/NCBI
|
|
22
|
Wu H, Xue R, Tang Z, Deng C, Liu T, Zeng
H, Sun Y and Shen X: Metabolomic investigation of gastric cancer
tissue using gas chromatography/mass spectrometry. Anal Bioanal
Chem. 396:1385–1395. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai Z, Zhao JS, Li JJ, Peng DN, Wang XY,
Chen TL, Qiu YP, Chen PP, Li WJ, Xu LY, et al: A combined
proteomics and metabolomics profiling of gastric cardia cancer
reveals characteristic dysregulations in glucose metabolism. Mol
Cell Proteomics. 9:2617–2628. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sambrook J and Russell DW: Molecular
Cloning: A Laboratory Manual. 3rd edition. Cold Spring Harbor
Laboratory Press; New York, NY: 2001
|
|
25
|
He J, Zhu G, Gao L, Chen P, Long Y, Liao
S, Yi H, Yi W, Pei Z, Wu M, et al: Fra-1 is upregulated in gastric
cancer tissues and affects the PI3K/Akt and p53 signaling pathway
in gastric cancer. Int J Oncol. 47:1725–1734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao S, Xiao S, Zhu G, Zheng D, He J, Pei
Z, Li G and Zhou Y: CD38 is highly expressed and affects the
PI3K/Akt signaling pathway in cervical cancer. Oncol Rep.
32:2703–2709. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baumann F, Leukel P, Doerfelt A, Beier CP,
Dettmer K, Oefner PJ, Kastenberger M, Kreutz M, Nickl-Jockschat T,
Bogdahn U, et al: Lactate promotes glioma migration by
TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro
Oncol. 11:368–380. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yokota H, Guo J, Matoba M, Higashi K,
Tonami H and Nagao Y: Lactate, choline, and creatine levels
measured by vitro 1H-MRS as prognostic parameters in patients with
non-small-cell lung cancer. J Magn Reson Imaging. 25:992–999. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Warburg OH: The classic: The chemical
constitution of respiration ferment. Clin Orthop Relat Res.
468:2833–2839. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin EH, Sung JK, Lee SI and Hong JH:
Mitochondrial NADH dehydrogenase subunit 3 (MTND3) polymorphisms
are associated with gastric cancer susceptibility. Int J Med Sci.
15:1329–1333. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Buglioni S, Melucci E, Sperati F, Pallocca
M, Terrenato I, De Nicola F, Goeman F, Casini B, Amoreo CA, Gallo
E, et al: The clinical significance of PD-L1 in advanced gastric
cancer is dependent on ARID1A mutations and ATM expression.
Oncoimmunology. 7:e14576022018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Malfertheiner P: Helicobacter pylori
treatment for gastric cancer prevention. N Engl J Med.
378:1154–1156. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pormohammad A, Ghotaslou R, Leylabadlo HE,
Nasiri MJ, Dabiri H and Hashemi A: Risk of gastric cancer in
association with Helicobacter pylori different virulence factors: A
systematic review and meta-analysis. Microb Pathog. 118:214–219.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Infection with Helicobacter pylori. IARC
Monogr Eval Carcinog Risks Hum. 61:177–240. 1994.PubMed/NCBI
|
|
37
|
Ma B, Cheng H, Mu C, Geng G, Zhao T, Luo
Q, Ma K, Chang R, Liu Q, Gao R, et al: The SIAH2-NRF1 axis
spatially regulates tumor microenvironment remodeling for tumor
progression. Nat Commun. 10:10342019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vander Heiden MG and Deberardinis RJ:
Understanding the intersections between metabolism and cancer
biology. Cell. 168:657–669. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Altman BJ, Stine ZE and Dang CV: From
Krebs to clinic: Glutamine metabolism to cancer therapy. Nat Rev
Cancer. 16:619–634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hu LP, Zhang XX, Jiang SH, Tao LY, Li Q,
Zhu LL, Yang MW, Huo YM, Jiang YS, Tian GA, et al: Targeting
purinergic receptor P2Y2 prevents the growth of pancreatic ductal
adenocarcinoma by inhibiting cancer cell glycolysis. Clin Cancer
Res. 25:1318–1330. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Choi SYC, Ettinger SL, Lin D, Xue H, Ci X,
Nabavi N, Bell RH, Mo F, Gout PW, Fleshner NE, et al: Targeting
MCT4 to reduce lactic acid secretion and glycolysis for treatment
of neuroendocrine prostate cancer. Cancer Med. 7:3385–3392. 2018.
View Article : Google Scholar
|
|
44
|
Ohashi T, Aoki M, Tomita H, Akazawa T,
Sato K, Kuze B, Mizuta K, Hara A, Nagaoka H, Inoue N and Ito Y:
M2-like macrophage polarization in high lactic acid-producing head
and neck cancer. Cancer Sci. 108:1128–1134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Piskounova E, Agathocleous M, Murphy MM,
Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ
and Morrison SJ: Oxidative stress inhibits distant metastasis by
human melanoma cells. Nature. 527:186–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fang WG and Tian XX: Identification of a
new pro-invasion factor in tumor microenvironment: Progress in
function and mechanism of extracellular ATP. Beijing Da Xue Xue Bao
Yi Xue Ban. 49:188–195. 2017.(In Chinese). PubMed/NCBI
|
|
47
|
Takai E, Tsukimoto M, Harada H, Sawada K,
Moriyama Y and Kojima S: Autocrine regulation of TGF-beta1-induced
cell migration by exocytosis of ATP and activation of P2 receptors
in human lung cancer cells. J Cell Sci. 125:5051–5060. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Alvarez A, Lagos-Cabre R, Kong M, Cárdenas
A, Burgos-Bravo F, Schneider P, Quest AF and Leyton L:
Integrin-mediated transactivation of P2X7R via
hemichannel-dependent ATP release stimulates astrocyte migration.
Biochim Biophys Acta. 1863:2175–2188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yao H, Su S, Xia D, Wang M, Li Z, Chen W,
Ren L and Xu L: F-box and leucine-rich repeat protein 5 promotes
colon cancer progression by modulating PTEN/PI3K/AKT signaling
pathway. Biomed Pharmacother. 107:1712–1719. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang H, Zhao Y, Cao L, Zhang J, Wang Y and
Xu M: Metastasis suppressor protein 1 regulated by PTEN suppresses
invasion, migration, and EMT of gastric carcinoma by inactivating
PI3K/AKT signaling. J Cell Biochem. 120:3447–3454. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Matsuoka T and Yashiro M: The role of
PI3K/Akt/mTOR signaling in gastric carcinoma. Cancers (Basel).
6:1441–1463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dupuy F, Tabariès S, Andrzejewski S, Dong
Z, Blagih J, Annis MG, Omeroglu A, Gao D, Leung S, Amir E, et al:
PDK1-dependent metabolic reprogramming dictates metastatic
potential in breast cancer. Cell Metab. 22:577–589. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Semenza GL and Wang GL: A nuclear factor
induced by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol Cell Biol. 12:5447–5454. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang GL and Semenza GL: Purification and
characterization of hypoxia-inducible factor 1. J Biol Chem.
270:1230–1237. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sáenz-de-Santa-María I,
Bernardo-Castiñeira C, Secades P, Bernaldo-de-Quirós S, Rodrigo JP,
Astudillo A and Chiara MD: Clinically relevant HIF-1α-dependent
metabolic reprogramming in oropharyngeal squamous cell carcinomas
includes coordinated activation of CAIX and the miR-210/ISCU
signaling axis, but not MCT1 and MCT4 upregulation. Oncotarget.
8:13730–13746. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Devignes CS, Aslan Y, Brenot A, Devillers
A, Schepers K, Fabre S, Chou J, Casbon AJ, Werb Z and Provot S: HIF
signaling in osteoblast-lineage cells promotes systemic breast
cancer growth and metastasis in mice. Proc Natl Acad Sci USA.
115:E992–E1001. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Vyas S, Zaganjor E and Haigis MC:
Mitochondria and Cancer. Cell. 166:555–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bringman-Rodenbarger LR, Guo AH, Lyssiotis
CA and Lombard DB: Emerging roles for SIRT5 in metabolism and
cancer. Antioxid Redox Signal. 28:677–690. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
De Matteis S, Granato AM, Napolitano R,
Molinari C, Valgiusti M, Santini D, Foschi FG, Ercolani G,
Vespasiani Gentilucci U, Faloppi L, et al: Interplay between
SIRT-3, metabolism and its tumor suppressor role in hepatocellular
carcinoma. Dig Dis Sci. 62:1872–1880. 2017. View Article : Google Scholar : PubMed/NCBI
|
